Partnerships for Diabetes Related Disparties in Hawaii

夏威夷糖尿病相关政党的合作伙伴关系

基本信息

  • 批准号:
    7124302
  • 负责人:
  • 金额:
    $ 43.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2009-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MedStar Research Institute (MRI) is the partnering institution of the University of Hawaii on Project EXPORT. The overall purpose of our joint application is to address health disparities among Native Hawaiians (NHs) and Pacific Peoples (PP; including Pacific Islanders and Filipinos) in Hawaii. Among NHs, the indigenous people of Hawaii, high rates of obesity and diabetes compared to the U.S. national rates are well known. In accordance with these trends, rates of cardiovascular disease (CVD) among NHs have been on the rise while rates in the general U.S. population have been decreasing. Despite the considerable burden of chronic disease among NHs, there is relatively little published data on the health of this population and even less is known about other Pacific Peoples (PPs). The sparse literature available on NH health disparities contrasts with the fact that several research projects focused on this topic have been initiated over the last 15 years. Part of the reason for the relative lack of published data on NH health is due to the fact that the State of Hawaii does not have a coordinated effort or critical mass of researchers and research infrastructures to (1) make use of its existing data resources on NH health and PPs, (2) support the growth of new research activities on health disparities among NHs or PPs or (3) promote the professional development of new investigators and research professionals. As a partner to the University of Hawaii in Project EXPORT, MRI will have three roles: (1) Provide statistical and data management support; (2) design and implement the Molokai Native Hawaiian Heart Health Study and (3) design and implement culturally appropriate clinical training programs for investigators, allied health professionals and community members. This partnership is based on MRIs experience conducting clinical research in American Indians (AI) and Alaska Natives (AN), populations with strikingly similar health profiles as NHs and PPs (obesity, diabetes and CVD). A partnership between the University of Hawaii and MRI in promoting research in NH and PP health through Project EXPORT will (1) address key deficiencies in research infrastructures that currently exist in Hawaii, and (2) provide MRI with an opportunity to extend its research experience in AI and AN to similar studies in a NH population. The mutually beneficial nature of this partnership will ensure that the goals of this center grant are achieved. This partnership will also form the groundwork for future opportunities to examine common correlates of health disparities among native populations in the U.S. that share similar inequities in health status.
描述(由申请人提供):MEDSTAR研究所(MRI)是夏威夷大学项目出口的合作机构。我们共同申请的总体目的是解决夏威夷原住民(NHS)和太平洋人民(包括太平洋岛民和菲律宾人)的健康差异。在NHS中,夏威夷的土著人民,肥胖和糖尿病的高率与美国全国率相比是众所周知的。根据这些趋势,NHS中心血管疾病(CVD)的发生率一直在上升,而美国普通人群的发生率一直在下降。尽管NHS中的慢性疾病负担很大,但关于该人群健康的数据相对较少,对其他太平洋人民(PPS)知之甚少。关于NH健康差异的稀疏文献与过去15年中启动了一些有关该主题的研究项目形成鲜明对比的事实。 Part of the reason for the relative lack of published data on NH health is due to the fact that the State of Hawaii does not have a coordinated effort or critical mass of researchers and research infrastructures to (1) make use of its existing data resources on NH health and PPs, (2) support the growth of new research activities on health disparities among NHs or PPs or (3) promote the professional development of new investigators and research professionals.作为夏威夷大学项目出口的合作伙伴,MRI将扮演三个角色:(1)提供统计和数据管理支持; (2)设计和实施MOLOKAI夏威夷本地夏威夷心脏健康研究,(3)为研究人员,盟友卫生专业人员和社区成员设计和实施适当的文化临床培训计划。该伙伴关系基于在美国印第安人(AI)和阿拉斯加土著人(AN)进行临床研究的MRI经验,其健康状况与NHS和PPS(肥胖,糖尿病和CVD)的健康状况非常相似。夏威夷大学和MRI通过项目出口促进NH和PP健康研究的合作伙伴关系(1)解决当前在夏威夷目前存在的研究基础设施中的关键缺陷,(2)MRI为MRI提供了扩展其在AI中的研究经验,并在NH人群中进行类似研究。该伙伴关系的互惠性质将确保实现该中心赠款的目标。这种伙伴关系还将为未来的机会构成基础,以检查美国本地人口中具有相似健康状况不平等的本地人口中的健康差异的共同相关性。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Diabetes and cardiovascular risk factors in Native Hawaiians.
夏威夷原住民的糖尿病和心血管危险因素。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Aluli,NEmmett;Jones,KristinaL;Reyes,PhillipW;Brady,SKalani;Tsark,JoAnnU;Howard,BarbaraV
  • 通讯作者:
    Howard,BarbaraV
Association of modifiable risk factors and left ventricular ejection fraction among hospitalized Native Hawaiians and Pacific Islanders with heart failure.
住院的夏威夷原住民和太平洋岛民心力衰竭的可改变危险因素与左心室射血分数之间的关联。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Barbara v Howard其他文献

Barbara v Howard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Barbara v Howard', 18)}}的其他基金

CVD in American Indians Biomarker lab and Arizona Field Center
美洲印第安人生物标记实验室和亚利桑那现场中心的 CVD
  • 批准号:
    8368909
  • 财政年份:
    2013
  • 资助金额:
    $ 43.77万
  • 项目类别:
CVD in American Indians Biomarker lab and Arizona Field Center
美洲印第安人生物标记实验室和亚利桑那现场中心的 CVD
  • 批准号:
    8665465
  • 财政年份:
    2013
  • 资助金额:
    $ 43.77万
  • 项目类别:
Partnerships for Diabetes Related Disparties in Hawaii
夏威夷糖尿病相关政党的合作伙伴关系
  • 批准号:
    6595678
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    7123667
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6459919
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6953654
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6667150
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    7692504
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6801125
  • 财政年份:
    2002
  • 资助金额:
    $ 43.77万
  • 项目类别:
GENETICS OF CORONARY ARTERY DISEASE IN ALASKAN NATIVES
阿拉斯加原住民冠状动脉疾病的遗传学
  • 批准号:
    6796417
  • 财政年份:
    2000
  • 资助金额:
    $ 43.77万
  • 项目类别:

相似国自然基金

三甲胺调控PEMT代谢通路对妊娠期糖尿病作用的临床及机制研究
  • 批准号:
    82200932
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
FTO通过m6A修饰LINC00921调控细胞铁死亡在糖尿病心肌梗死中的临床价值及机制研究
  • 批准号:
    82272407
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
FTO通过m6A修饰LINC00921调控细胞铁死亡在糖尿病心肌梗死中的临床价值及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
三甲胺调控PEMT代谢通路对妊娠期糖尿病作用的临床及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中韩糖尿病并发症中医药临床及实验研究进展研讨会
  • 批准号:
    82181340280
  • 批准年份:
    2021
  • 资助金额:
    4.3 万元
  • 项目类别:

相似海外基金

Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
亚裔美国人预防研究:人口组学流行病学队列 (ARISE)
  • 批准号:
    10724884
  • 财政年份:
    2023
  • 资助金额:
    $ 43.77万
  • 项目类别:
Asian American Community Cohort of the New York Metropolitan Area
纽约都会区亚裔美国人社区群体
  • 批准号:
    10724342
  • 财政年份:
    2023
  • 资助金额:
    $ 43.77万
  • 项目类别:
Asian American Community Cohort and Equity Study (ACCESS)
亚裔美国人社区队列和公平研究 (ACCESS)
  • 批准号:
    10724846
  • 财政年份:
    2023
  • 资助金额:
    $ 43.77万
  • 项目类别:
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
表观转录组作为砷诱发糖尿病的新机制。
  • 批准号:
    10747037
  • 财政年份:
    2023
  • 资助金额:
    $ 43.77万
  • 项目类别:
I-TrainED: Innovative Training and Education in Diabetes
I-TrainED:糖尿病创新培训和教育
  • 批准号:
    10795135
  • 财政年份:
    2023
  • 资助金额:
    $ 43.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了